BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 25, 2011
 |  BC Week In Review  |  Company News  |  Deals

Kinex Pharmaceuticals, Hanmi Pharmaceutical deal

Kinex granted Hanmi exclusive rights to develop and commercialize KX01 ( KX2-391) for all oncology indications in Korea, China and some...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >